Pas Research

Tampa, Florida 33613

2 studies enrolling now · 15 studies all time

What they study most

Acute Respiratory Infections (ARIs), Acute Respiratory Tract Infections, COVID-19, Covid19, Growth, Healthy, Infant Development, Infants, Measles, Measles-Mumps-Rubella+Chickenpox Vaccine, Meningococcal Vaccine, Migraine

Studies at this site

• FebriDx® Pediatric Validation Study — Recruiting now
• A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children — Completed
• A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of Age — Starting soon
• Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection — Stopped early
• A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants — Running, not enrolling
• Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273.214 SARS-CoV-2 (COVID-19) Vaccine in Infants — Stopped early
• Study of Obeldesivir in Children and Adolescents With COVID-19 — Stopped early
• A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine — Completed
• Growth and Tolerance of a Partially Hydrolyzed Infant Formula — Completed
• MenABCWY Noninferiority Study in Healthy Participants ≥10 to <26 Years of Age — Completed
• FebriDx DISRUPT Acute Respiratory Infection Trial in Acute Respiratory Infection: An Evaluation of FebriDx® POC Test — Completed
• Clinical Evaluation of a COVID-19 Antigen Self-Test (CoviDx™) — Stopped early
• Phase II Growth and Safety Study of an Infant Formula for Healthy Term Infants — Completed
• Follow-up Study of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants — Completed
• Evaluation of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants — Completed